Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 987

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Trends in the Aggressiveness of Cancer Care Near the End of Life

Earle, Craig C., Neville, Bridget A., Landrum, Mary Beth, Ayanian, John Z., Block, Susan D., Weeks, Jane C. · 2004 · Journal of Clinical Oncology

Abstract

Purpose: To characterize the aggressiveness of end-of-life cancer treatment for older adults on Medicare, and its relationship to the availability of healthcare resources. Patients and Methods: We analyzed Medicare claims of 28,777 patients 65 years and older who died within 1 year of a diagnosis of lung, breast, colorectal, or other gastrointestinal cancer between 1993 and 1996 while living in one of 11 US regions monitored by the Surveillance, Epidemiology, and End Results Program. Results: Rates of treatment with chemotherapy increased from 27.9% in 1993 to 29.5% in 1996 (P = .02). Among those who received chemotherapy, 15.7% were still receiving treatment within 2 weeks of death, increasing from 13.8% in 1993 to 18.5% in 1996 (P < .001). From 1993 to 1996, increasing proportions of patients had more than one emergency department visit (7.2% v 9.2%; P < .001), hospitalization (7.8% v 9.1%; P = .008), or were admitted to an intensive care unit (7.1% v 9.4%; P = .009) in the last month of life. Although fewer patients died in acute-care hospitals (32.9% v 29.5%; P < .001) and more used hospice services (28.3% v 38.8%; P < .001), an increasing proportion of patients who received hospice care initiated this service only within the last 3 days of life (14.3% v 17.0%; P = .004). Black patients were more likely than white patients to experience aggressive intervention in nonteaching hospitals but not in teaching hospitals. Greater local availability of hospices was associated with less aggressive treatment near death on multivariate analysis. Conclusion: The treatment of cancer patients near death is becoming increasingly aggressive over time.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2004.08.136

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 13

  1. 10.1093/oxfordjournals.annonc.a058808 · doi:10.1093/oxfordjournals.annonc.a058808
  2. Comis RL, Friedland DM: New chemotherapy agents in the treatment of advanced non-small cell lung cancer: An update including data from the Seventh World conference on Lung Cancer. Lung Cancer 12: S63,1995-S99, (suppl 2) · doi:10.1016/s0169-5002(10)80007-8
  3. 10.1093/oxfordjournals.annonc.a059040 · doi:10.1093/oxfordjournals.annonc.a059040
  4. 10.1002/(SICI)1097-0142(19980815)83:4<679::AID-CNCR8>3.0.CO;2-F · doi:10.1002/(sici)1097-0142(19980815)83:4<679::aid-cncr8>3.0.co;2-f
  5. 10.1097/00001813-199801000-00002 · doi:10.1097/00001813-199801000-00002
  6. Institute of Medicine: Improving Palliative Care for Cancer . Washington, DC, National Academy Press, p,2001 1
  7. Kurowski B: Cancer carve outs, specialty networks, and disease management: A review of their evolution, effectiveness, and prognosis. Am J Manag Care 4: SP71,1998-SP89,
  8. 10.1002/(SICI)1097-0142(19980515)82:10+<2061::AID-CNCR15>3.0.CO;2-9 · doi:10.1002/(sici)1097-0142(19980515)82:10+<2061::aid-cncr15>3.0.co;2-9
  9. 10.1002/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-# · doi:10.1002/1097-0142(19951201)76:11<2343::aid-cncr2820761124>3.0.co;2-#
  10. Ries LAG, Kosary CL, Hankey BF, et al: SEER Cancer Statistics Review, 1973-1994 . Bethesda, MD, National Cancer Institute, NIH publication 97-2789, 1997
  11. Institute of Medicine: Approaching Death . Washington, DC, National Academy Press, 1997
  12. 10.1111/j.1532-5415.1997.tb05185.x · doi:10.1111/j.1532-5415.1997.tb05185.x
  13. 10.1016/S0885-3924(98)00132-8 · doi:10.1016/s0885-3924(98)00132-8

Cited by

See all 987

Metadata

Authors
Earle, C. C., Neville, B. A., Landrum, M. B., Ayanian, J. Z., Block, S. D., & Weeks, J. C.
Venue
Journal of Clinical Oncology
Published
2004-01-15
Volume
22
Issue
2
Pages
315-321
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2096448257
Cited by
987
References
24
FWCI
25.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.